Table 3.

Comparison of demographics and clinical characteristics of the 25 chronic patients according to the type of liver damage.

	Hepatocellular N = 15	Cholestatic/mixed N = 10
Age years, mean (range)	62 (30-83)	64 (40-78)
Female, n (%)	9 (60)	7 (70)
Jaundice, n (%)	13 (87)	7 (70)
Hypersensitivity features, n (%)	3 (20)	6 (60)
Liver biopsy*, n (%)	10 (67)	6 (60)
Fibrosis, n (%)	1 (7)	0
Cirrhosis, n (%)	5 (33)	2 (20)
Ductal lesion, n (%)	0	2 (20)
Steatosis, n (%)	2 (13)	2 (20)
Biochemical normalization ≤3 years, n (%)	7 (47)	1 (10)

Hypersensitivity features: Presence of one or more positive features such as fever, rash, arthralgia, peripheral eosinophilia or lymphopenia. The time of biopsy performances varies from 2 weeks to 60 months after DILI onset.